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3-phosphocholine; PC: phosphatidylcholine; PEIPC: 1-palmitoyl-2-epoxyisoprostaneE2-sn-33 
glycero-3-phosphocholine; PGPC: 1-palmitoyl-2-glutaryl-sn-glycero-3-phosphocholine; 34 
POVPC: 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine; PL: phospholipid; 35 
TS: truncation score; XIC: Extracted ion chromatograms. 36 
 37 
Abstract 38 
Oxidized LDL (oxLDL) has been shown to play a crucial role in the onset and 39 
development of cardiovascular disorders. The study of oxLDL, as an initiator of 40 
inflammatory cascades, led to the discovery of a variety of oxidized phospholipids (oxPLs) 41 
responsible for pro-inflammatory actions. Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-42 
phosphocholine (PAPC) is frequently used by the scientific community as a representative 43 
oxPL mixture to study the biological effects of oxidized lipids, due to the high abundance of 44 
PAPC in human tissues and the biological activities of oxidized arachidonic acids derivatives. 45 
Most studies focusing on oxPAPC effects rely on in-house prepared mixtures of oxidized 46 
species obtained by exposing PAPC to air oxidation. Here, we described a multi-laboratory 47 
evaluation of the compounds in oxPAPC by LC-MS/MS, focusing on the identification and 48 
relative quantification of the lipid peroxidation products (LPPs) formed. PAPC was air-49 
oxidized in four laboratories using the same protocol for 0, 48, and 72 hours. It was possible 50 
to identify 55 different LPPs with unique elemental composition and characterize different 51 
structural isomeric species within these. The study showed good intra-sample reproducibility 52 
and similar qualitative patterns of oxidation, as the most abundant LPPs were essentially the 53 
same between the four laboratories. However, there were substantial differences in the extent 54 
of oxidation, i.e. the amount of LPPs relative to unmodified PAPC, at specific time points. 55 
This shows the importance of characterizing air-oxidized PAPC preparations before using 56 
them for testing biological effects of oxidized lipids, and may explain some variability of 57 
effects reported in the literature.  58 
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Graphical Abstract 59 
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1. Introduction 63 
The role of oxidized LDL as an initiator of inflammatory cascades that contribute to the 64 
pathogenesis of cardiovascular disorders including atherosclerosis, led to the discovery of a 65 
variety of oxidized phospholipids (oxPLs) important for the fine tuning of innate and 66 
adaptive immune responses [1–3]. OxPLs formed via enzymatic or free-radical driven 67 
reactions are closely associated with systemic redox imbalance and low-grade chronic 68 
inflammation, and thus have been intensively studied from structural, chemical, biophysical, 69 
and biological perspectives over the last decades[4–8]. Within the generic classification of 70 
oxPL, the oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine 71 
(PAPC), which have been identified as some of the bioactive components in minimally 72 
modified LDL, are the oxPLs most often used to study the biological effects of oxidized 73 
lipids [9]. Furthermore, PAPC is among the most abundant PLs in human tissues [10]. 74 
Arachidonic acid, present in the sn-2 position of PAPC, can form a very diverse range of 75 
oxidation products, many of which have already been shown to be bioactive in their free fatty 76 
acid forms. Indeed, numerous studies have demonstrated the pro- and anti-inflammatory 77 
properties of, for example, eicosanoids, which are generated from arachidonic acid via action 78 
of dedicated enzymes or free radical driven lipid peroxidation [11–13]. However, the action 79 
of PC-esterified eicosanoids has been relatively less well studied.  80 
A variety of bioactivities have been attributed to oxidized PAPC (oxPAPC). It has been 81 
identified as a major pro-atherogenic factor and pro-inflammatory mediator [14,15], but in 82 
contrast anti-inflammatory properties of oxPAPC have also been demonstrated [13,16]. 83 
OxPAPC has been shown to induce both the disruption as well as enhancement of the 84 
endothelial barrier [17,18], and recently a pro-algesic effect of oxPAPC, via stimulation of 85 
transient receptor potential channels TRPA1 and TRPV1, was demonstrated [19,20]. 86 
OxPAPC was also shown to act as a damage associated molecular pattern (DAMP), 87 
activating classical and non-classical pattern recognition receptors. Thus, oxPAPC released 88 
from injured tissues was shown to be recognized by murine caspase-11 and CD14 leading to 89 
inflammasome activation and release of pro-inflammatory cytokines, and this pathway 90 
demonstrated differential regulation in macrophages and dendritic cells [21–23]. The variety 91 
of biological effects of oxPAPC are well established and their conflicting properties have 92 
been discussed recently [24–26].  93 
One of the main obstacles in elucidating the effects oxPLs on biological systems is the 94 
almost complete lack of commercially available and chemically characterized standards for 95 
each individual oxPL product. Thus, to study their biological properties, a mixture of 96 
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products, usually referred to as “oxPAPC” is often used. The majority of the studies on 97 
oxPAPC effects rely on commercial or in-house preparations, usually obtained by exposing a 98 
dried film of PAPC to air oxidation for up to 72 h. Experimental details such as room 99 
temperature, light exposure, thickness of the phospholipid film and oxPAPC quality control 100 
are usually not provided. Given the variety of biological functions attributed to oxPAPC in 101 
different cellular and in vivo models, which may be dependent on variations in sample 102 
preparation affecting the precise composition of the oxPAPC, we performed a multi-103 
laboratory study with the aim of evaluating the reproducibility of PAPC oxidation upon air 104 
exposure for 48 and 72 h. Liquid chromatography coupled on-line to tandem mass 105 
spectrometry (LC-MS/MS) was used to identify lipid peroxidation products (LPPs) formed 106 
upon PAPC oxidation, and the relative quantities of LPPs formed were compared between 107 
samples generated independently in four different international laboratories.  108 
 109 
2. Materials and Methods 110 
2.1. Materials 111 
1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine and 1,2-dimyristoyl-sn-112 
glycero-3-phosphocholine were purchased from Avanti Polar Lipids (Avanti Polar Lipids, 113 
Inc., Alabama, USA). In laboratory 1 (L1) acetonitrile, isopropanol, water, methanol, 114 
ammonium formate (Optima LC-MS grade), chloroform and formic acid (LC-MS grade) 115 
were obtained from Fisher Scientific (Loughborough, UK). In laboratory 2 (L2) HPLC-MS 116 
grade chloroform, methanol, acetonitrile and isopropanol were purchased from Fisher 117 
Scientific (Leicestershire, UK). Formic acid was from Honeywell Fluka (Neu Wulmstorf, 118 
Germany). Ammonium formate was obtained from Sigma-Aldrich (Sigma-Aldrich, Munich, 119 
Germany). The water was of Milli-Q purity (Synergy1, Millipore Corporation, Billerica, 120 
MA). In laboratory 3 (L3) acetonitrile, isopropanol, water, methanol, ammonium formate 121 
(OptimaTM LC/MS grade) and chloroform (LC/MS grade) were obtained from Fisher 122 
Scientific (Schwerte, Germany). Formic acid (LC-MS grade) was purchased from Sigma-123 
Aldrich (Sigma-Aldrich, Munich, Germany). In laboratory 4 (L4) acetonitrile, isopropanol, 124 
methanol, and formic acid (all ULC-MS grade) were from Biosolve (Valkenswaard, 125 
Netherlands). Ammonium formate and chloroform were from Sigma-Aldrich GmbH 126 
(Taufkirchen, Germany). 127 
2.2. OxPAPC preparation.  128 
OxPAPC was prepared either in one laboratory (L3) or independently in four 129 
participating laboratories following the protocol describe below. A mixture of 1-palmitoyl-2-130 
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linoleoyl-sn-glycero-3-phosphocholine (PAPC; 50 µg) and 1-2-dimiristoyl-sn-glycero-3-131 
phosphocholine (DMPC; 2.2 µg; a fully saturated PC used as internal standard for relative 132 
quantification) in chloroform was dried under a stream of N2 in a 2 mL amber flat bottom vial 133 
to form a thin film at the vial bottom (three independent replicates). The lipid film was 134 
exposed to air at room temperature (L1 – 22-25°C, L2 – 16°C,  L3 – 28°C,   L4 – 25°C) for 0, 135 
48 and 72 hours. After incubation the vial was filled with N2, tightly sealed and stored at -136 
80°C. Samples from L3 were sent to the other laboratories on freezer blocks at -20°C . 137 
2.3. LC-MS/MS analysis. 138 
The experimental replicates (n=3) of sample prepared in L3 (0 and 72 h of oxidation; 139 
analysed by L1, L3, and L4), as well as samples generated independently in each of the four 140 
participating laboratories and analysed there, were used to assess inter-laboratory variability. 141 
In L4, experimental replicate 1 was analysed in triplicate on three consecutive days, to assess 142 
intra- and inter-day analytical variability. Comparable chromatographic conditions and the 143 
best available tandem MS instrument were used in the 4 laboratories. Details on LC-MS/MS 144 
are provided in Table 1 and Supplementary Methods section. Briefly, UHPLC separations 145 
were performed on C18 reverse phase columns using binary solvent systems containing 146 
water, acetonitrile, methanol and isopropanol, with ammonium formate (5 mmol/L) and 147 
formic acid (0.1%) as additives [27]. MS analyses were performed using data-dependent 148 
acquisition (DDA) in positive and negative ion modes (Table 1 and Supplementary 149 
Methods).   150 
2.4. Automated identification of lipid peroxidation products (LPPs).  151 
LPPtiger software source code version was used for lipid identification ([28]; 152 
https://bitbucket.org/SysMedOs/lpptiger). PAPC was oxidized in silico using theoretical 153 
oxidation level 2. The list of modifications included hydroperoxy, hydroxy, epoxy, and keto 154 
groups with the maximum number equal to the number of bis-allylic and allylic sites in the 155 
structure. The oxidative cleavage products with aldehyde and carboxylic acid on the terminal 156 
carbon were included. LPPtiger predicted 345 unique oxidized fatty acyl chains 157 
corresponding to 692 discrete oxPAPC species including lyso species. All raw spectra were 158 
converted into mzML format using ProteoWizard MSconvert (Version 3.0.9134 64bit) and 159 
the following parameters were used for all files: m/z range 400 to 1000, isotope score filter 160 
80, and overall score filter 40. For L1 files 50 ppm on MS level and 200 ppm on MS2 level 161 
were used as mass tolerance thresholds. For L2, L3, and L4 mass tolerance of 10 ppm on MS 162 
and MS2 levels was applied. Analysis was performed using the integrated batch mode of 163 
LPPtiger on a workstation equipped with 2 CPUs (32 cores) and 128 GB of RAM in L4. 164 
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2.5. Relative LPPs quantification. 165 
15 LPPs detected in all four laboratories and previously reported in the literature as a 166 
component of oxPAPC [9,11,13,14,16–18,23,29,30] were chosen for the relative 167 
quantification (Table 2). Peak area for each lipid was integrated and normalized relative to 168 
the DMPC lipid used as non-oxidizable internal standard. Average percent values for each 169 
LPP relative to PAPC were calculated using normalized peak areas.  170 
2.6. Statistical analysis.  171 
Coefficient of variation (CV%) was calculated using the following equation CV% = 172 
DevSTD/AverageRelativeArea*100 for each LPPs using normalized peak areas. Principal 173 
component analysis was performed using normalized peak area of 15 LPPs from L3 prepared 174 
samples analyzed by three laboratories (L1, L3 and L4) using EZinfo (version 1.0, MKS 175 
Instruments, Crewe, UK). ANOVA (Single Factor) analysis was performed by Analysis 176 
ToolPak Excel Add-In for each LPPs using normalized peak areas. 177 
2.7. Nomenclature.  178 
Lipid nomenclature is based on the LIPID MAPS consortium recommendations [31]. 179 
For instance, the shorthand notation PC 36:4 represents a phosphatidylcholine lipid 180 
containing 36 carbons and four double bonds. When the fatty acid identities and sn-position 181 
are known, as in our case, the slash separator is used (e.g., PC 16:0/20:4). Since no unified 182 
nomenclature is available for oxidized lipids, the short hand notations provided by LPPtiger 183 
tool were used [28]. Short chain oxidized lipids were indicated by the corresponding terminal 184 
enclosed in angular brackets (e.g. “<” and “>”), with the truncation site indicated by the 185 
carbon atom number (e.g., <COOH@C9> and <CHO@C12). For long chain products our 186 
recommendation is to indicate the number of oxygen addition after the fully identified parent 187 
lipid (e.g. PC 16:0/20:4 + 1O) when the type of addition is not known, or in parenthesis for 188 
known functional groups (e.g. PC 16:0/20:4[1xOH@C11]). 189 
 190 
 191 
 192 
 193 
 194 
 195 
 196 
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Table 1. Summary of LC-MS/MS methods used for the analysis of oxPAPC in four different 197 
laboratories.  198 
 L1 L2 L3 L4 
Chromatography 
Column Accucore™ C18 ACE C18 Accucore™ C18 Accucore™ C18 
Column phase Solid core, C18 Solid core, C18 Solid core, C18 Solid core, C18 
Dimensions 150 x 2.1 mm 150 x 0.5 mm 150 x 2.1 mm 150 x 2.1 mm 
Particle size 2.6 µm 5 µm 2.6 µm 2.6 µm 
Pore size 150 Å 100 Å 150 Å 150 Å 
Gradient 
isopropanol: 
acetonitrile: 
water 
isopropanol: 
methanol: 
acetonitrile: 
water 
isopropanol: 
acetonitrile: 
water 
isopropanol: 
acetonitrile: 
water 
Temperature 50 °C 40 °C 50 °C 50 °C 
Tandem MS 
Instrument 5600 TripleTOF Q Exactive™ 
Orbitrap 
Fusion™ 
Lumos™ 
Tribrid™ 
Q Exactive™ 
Plus 
MS1 200-1500 m/z 400–1200 m/z 450–1200 m/z  380–1200 m/z  
Resolution  High sensitivity 70,000 120,000 140,000 
DDA top # 5 5 15 10 
Fragmentation CID HCD HCD HCD 
CE 35V, 10V CES NCE 20, 23, 25 NCE 20 +/- 10 NCE 18 +/- 6 
Resolution 
MS2 High sensitivity 17,500 15,000 17,500 
  199 
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3. Results and Discussion  200 
3.1. Identification of LPP species in air oxidized PAPC.  201 
To evaluate the extent of PAPC oxidation and identify the LPPs formed, oxPAPC 202 
samples prepared in four different laboratories (L1-L4) were analysed by LC-MS/MS using 203 
reverse phase separation on C18 columns and data-dependent acquisition on four different 204 
MS instruments (Table 1). OxPAPC mixtures were analysed in both positive and negative 205 
ion modes. Positive ion mode data were used for relative quantification, given the higher 206 
ionization efficiency of PC lipids as protonated quasi-molecular ions, whereas the negative 207 
ion mode data were used for identification of LPPs based on tandem mass spectra of the 208 
formate adduct or deprotonated ions, as the negative ion fragmentation data contains 209 
informative fragment anions of the modified acyl chains.  210 
Fig. 1 shows representative positive ion mode base peak chromatograms for three 211 
different time points of PAPC oxidation obtained from the four laboratories. Representative 212 
negative ion mode base peak chromatograms are shown in Supplementary Fig. S1. DMPC, 213 
which contains two fully saturated C14:0 acyl chains, was spiked into all preparation at equal 214 
quantities (PAPC:DMPC, 20:1 molar ratio) and was used as an internal standard for relative 215 
quantification. The general pattern of oxidation was very similar between all laboratories. At 216 
the 0 h time point two main signals, corresponding to DMPC (m/z 678. 51+) and native PAPC 217 
(m/z 782. 57+), are clearly visible, with almost a complete absence of LPPs. After 48 h of air 218 
exposure, a large number of signals for analytes with shorter retention times than PAPC can 219 
be observed, indicating the presence of species with higher polarities than native PAPC. After 220 
72 h, most of the signals eluted towards the beginning of chromatographic gradients, 221 
generally in the first third, corresponding to chain-shortened oxidation products, accompanied 222 
by a corresponding decrease of the signals eluting in the middle third of the gradient, 223 
corresponding to long-chain oxidised products, as well a decrease the native PAPC signal 224 
which appears towards the end of the gradient. 225 
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 226 
Fig. 1. Positive ion mode base peak chromatograms of PAPC lipid oxidized by air exposure 227 
for 0, 48 and 72 h and analysed using reverse phase chromatography coupled on-line to 228 
tandem mass spectrometry detection in L1 (A), L2 (B), L3 (C) and L4 (D).  229 
 230 
LPPtiger, a new software for the identification of oxidized phospholipids from data-231 
dependent LC-MS/MS datasets, was used for the automated identification of LPPs in the 232 
oxPAPC preparations [28]. LPPtiger performs identification based on the fragment ions 233 
observed in CID or HCD experiments in the negative ion mode. The presence of specific 234 
anions corresponding to native and oxidized acyl chains in PLs allows identification of the 235 
oxidation type, whereas fragment ions and specific neutral losses provides identification of 236 
PL class. Identification of positional isomers of oxPL is not supported by the current version 237 
of the software, but the MS/MS based identification of oxidized fatty acyl chains together 238 
with isotopic scores correction provide a solid basis for the identification of molecular 239 
species.  240 
Overall 55 different LPPs with unique elemental compositions were identified, 241 
providing 143 potential LPPs after considering functional group isomers (Supplementary 242 
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Table S1). The 55 identified LPPs covered a number of different types of oxidative products, 243 
including the lysophosphatidylcholines (LPC) LPC(16:0) and LPC(20:4), as well as 40 short 244 
chain and 15 long chain LPPs. 24 LPPs were identified by all three laboratories that 245 
performed DDA analysis (L2 used an inclusion list function and thus was not considered for 246 
this comparison), and 45 LPPs were identified by two laboratories. Overall, all of the main 247 
LPPs generally regarded as being present in oxPAPC mixtures were successfully identified 248 
by LPPtiger at the MS/MS level, including the truncated species 1-palmitoyl-2-(5-249 
oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC; m/z 594.38+) and 1-palmitoyl-2-250 
glutaryl-sn-glycero-3-phosphocholine (PGPC; m/z 610.37+), long chain products with 251 
hydroperoxy, hydroxy, and keto groups, and 1-palmitoyl-2-epoxyisoprostaneE2-sn-glycero-252 
3-phosphocholine (PEIPC; m/z 828.54+).  253 
The different numbers of LPPs identified by LPPtiger from the MS/MS data from the 254 
four laboratories most probably relates to the differences in MS methods and instruments 255 
used in the study. Thus, the highest number of LPPs was identified by L3 utilizing a Tribid 256 
Orbitrap Fusion Lumos, which is capable of acquiring a high number of tandem mass spectra 257 
(15 MS/MS) per one survey scan, followed by L4 and L1 in which top 10 and top 5 DDA 258 
methods were applied using a Q Exactive™ Plus and a TripleToF 5600 respectively. L2 259 
performed targeted acquisition using inclusion lists for 63 LPPs, of which 12 were 260 
successfully identified.  261 
3.2. LC-MS/MS based identification of isomeric LPPs.  262 
Reverse phase chromatographic separation allowed the resolution of multiple isomeric 263 
LPP species. The C18 phase proved to be a good stationary phase for the separation of the 264 
relatively polar analytes formed by the oxidation of PLs, which are characterized by a mid-265 
range polarity compared to the other lipid classes. Reverse phase separation strongly depends 266 
on the hydrophobicity of the analyte, usually described by the partition coefficients logP and 267 
logD [32], along with to a lesser extent some other physico-chemical properties, such as 268 
dipole-dipole interactions, proton acceptor/donor interactions and analyte polarizability. In 269 
comparison with native PAPC, which has a logP 8.4, introduction of a single hydroxy group 270 
results a shift of the logP to 7.2, whereas presence of three hydroxy groups or the isoprostane 271 
ring structures (e.g. PGF2α) further shifts the logP values further to 5.1 and 4.5, respectively. 272 
The use of a C18 stationary phase with an isopropanol-acetonitrile-water elution gradient 273 
ensures optimal binding of these mid-polarity lipid analytes while still providing efficient 274 
separation of lipid species. The combination of LC separation with tandem mass 275 
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spectrometry allows the acquisition of separate tandem mass spectra for the separated 276 
isomeric LPPs, and CID or HCD fragment spectra acquired in the negative ion mode 277 
provides the information necessary to identify the type and often the position of the 278 
modification.  279 
Fig. 2 illustrates three examples of LC-MS/MS based identification of short chain 280 
oxPAPC species.  281 
Extracted ion chromatograms (XICs) for POVPC (Fig. 2) in negative ([M+HCOOH-282 
H+], m/z 638.37) and positive ([M+H+], m/z 594.38) ion modes both had two 283 
chromatographic peaks with a retention times of 5.6 and 6.1 min. Although the POVPC 284 
signal was already present at the 0 h oxidation time point, the intensity of this LPP increased 285 
by more than two orders of magnitude over the oxidation time course (e.g. from 5e4 counts at 286 
0h to 8e6 counts at 72 h for the example shown in Fig. 2 of the analysis performed by L3). 287 
The positive mode HCD tandem mass spectra showed the presence of the fragment ion 288 
characteristic of the PC head group at m/z 184, whereas the negative ion mode tandem mass 289 
spectra acquired at 5.1 and 6.1 min provided more detailed information on LPP structure. For 290 
example, the fragment ion at m/z 578.35 corresponded to the loss of formate and a methyl 291 
group, a characteristic loss for the PC head group. The most informative region was where 292 
anions of palmitic acid (m/z 255.23) and the five carbon long modified acyl chain with a C5 293 
terminal aldehyde could be detected (m/z 155.04). The differences in MS/MS spectra taken at 294 
the different retention times can most likely be attributed to the sn-1/sn-2 positions of the two 295 
fatty acyl chains. Thus, the most intense signal eluting at 6.1 min most probably corresponds 296 
to 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine whereas the signal at 5.6 297 
min, which has a higher intensity of the m/z 115.04 ion, is probably due to the positional 298 
isomer 1-(5-oxovaleroyl)-2-palmitoyl-sn-glycero-3-phosphorylcholine [33,34]. Similarly, 299 
two chromatographic peaks were observed in the XIC at the mass of PGPC (Supplementary 300 
Fig. S2), and the XICs generated from both positive and negative mode data showed up to a 301 
three orders of magnitude increase in PGPC signal over the oxidation time course. The 302 
fragmentation data showed a different ratio between the anionic acyl chain fragment 303 
intensities (m/z 255.23 for palmitic and m/z 113.02 and 145.05 for glutaric acid), and the 304 
fragmentation spectra in negative ion mode were characterized by the diagnostic neutral loss 305 
of 59 Da from the parent (fragment at m/z 549.28), corresponding to loss of CH3COOH from 306 
a terminal carboxylic acid, and the two fragment ions related to the short chain oxidized FA 307 
(m/z 113.02 and 145.05). These fragmentations with a ∆m of 32 Da are due to the 308 
rearrangement of the polar head group, as has been described previously [35].  309 
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 310 
1-palmitoyl-2-(5-hydroxy-8-oxo-octenoyl)-sn-glycero-3-phosphorylcholine 311 
(HOOAPC), a previously reported short chain oxidized lipid in oxPAPC preparations, was 312 
also already present at time 0 h, and increased with time by up to two orders of magnitude 313 
(Supplementary Fig. S3). Once more, it was possible to identify the presence of two 314 
chromatographic peaks showing a different ratio between the intensities of the acyl chain 315 
anion signals. The loss of formate and methyl groups in negative ion mode and the polar head 316 
group PC characteristic fragments in positive ion mode were observed. A diagnostic ion 317 
confirming the hydroxyl group to be on an eight carbon long truncated acyl chain was present 318 
at m/z 153.06, resulting from water loss relative to the short chain oxidized FA (m/z 171.07). 319 
Fig. 3 shows three examples of LC-MS/MS based identification of long chain oxPAPC 320 
species. In this case, the XICs are much more complex than for the short chain LPPs, 321 
indicating the presence of multiple isomeric species. For example, at least 11 different 322 
chromatographic peaks, 8 of them showing baseline separation, were detected for a mass 323 
corresponding to PAPC with the addition of one oxygen (Fig. 3). Furthermore, the 324 
chromatographic profile differed at the three oxidation time points. At 0 h all 11 peaks were 325 
present, while after 72 h some had disappeared. The fragmentation spectra in positive ion 326 
mode showed, as expected, a major fragment ion from the PC head group, but it was also 327 
possible to see a fragment ion resulting from the loss of 18 Da, corresponding to the loss of 328 
H2O which is diagnostic of an OH group. Negative ion mode tandem mass spectra allowed 329 
the identification of many of the modification isomers. Thus, the isomeric PAPC oxidation 330 
products with a hydroxy (RT 13.1) or an epoxy (RT 13.9) group were identified based on the 331 
diagnostic ions at m/z 127.08 and 155.07 respectively, with the hydroxy group identified as 332 
being at position C7, and the epoxy group at C5-C6 (from the ion at m/z 191.18).  333 
Supplementary Fig. S4 shows the identification of PAPC with the addition of two 334 
oxygens, where the XIC shows six main peaks at time points 0 h and 48 h, while at 72 h 335 
additional chromatographic peaks with shorter retention times were present. In positive ion 336 
mode the earlier eluting peaks showed one and two neutral losses of water molecules (-18 337 
and -36 Da), typical of diHETE derivatives, while the later eluting signals were characterized 338 
by the neutral losses of 18 and 34 Da, diagnostic of lipid hydroperoxides. Furthermore, with 339 
these species for the first time we could identify in negative ion mode a diagnostic fragment 340 
ion (m/z 335.22) from the diHETE-PC, corresponding to arachidonic acid carrying two 341 
hydroxyl groups, whereas for the hydroperoxide containing oxPAPC the predominant signal 342 
was detected at m/z 317.21 (single water loss). Occasionally, it was even possible to detect a 343 
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signal at m/z 331.23 corresponding to [FA 20:4 + OOH - 2H] and characteristic fragments 344 
ions at 203.18 and 129.06 m/z, diagnostic for a hydroperoxide group at position C5. 345 
Supplementary Fig. S5 demonstrates the identification of a long chain oxidized PAPC 346 
derivative characterized by the addition of three oxygen atoms and the loss of two hydrogens. 347 
The intensity over the oxidation time course increased by one order of magnitude between 0 348 
and 48 h and then remained approximately constant. The most studied product with this mass 349 
is PEIPC. The fragmentation spectrum in negative ion mode is shown in Supplementary 350 
Fig. 5B. All previously reported [36] diagnostic fragment ions were present (m/z 331.19, 351 
313.18, 305.21, 287.21, 269.19), including the characteristic ions for the epoxy group at the 352 
position C5-C6 (m/z 233.15, 215.14, 203.14, 147.07, 115.04). In positive ion mode the 353 
fragmentation spectra were characterized by the PC-specific fragment ion (184.07 m/z) and 354 
diagnostic OH neutral losses (loss of 18 and 36 Da).   355 
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 356 
Fig. 2. Extracted ion chromatograms (A), HCD tandem mass spectra in negative (B), and 357 
positive ion modes (C) and proposed structure (D) of POVPC. Color-coding of structure-358 
related signals in the negative mode MS/MS spectra (e.g. the anion of FA 16:0 in blue, oxFA 359 
in orange and green, and LPC fragment derived as NL of one FA in pink) corresponds to the 360 
color-coding of fragments assigned to proposed structures illustrated in the lower panel. 361 
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 362 
Fig. 3. Extracted ion chromatograms (A), HCD tandem mass spectra in negative (B), and 363 
positive ion mode (C) and proposed structure (D) of PAPC with the addition of one oxygen. 364 
Color-coding of structure-related signals in negative mode MS/MS spectra (e.g. the anion of 365 
FA 16:0 in blue, oxFA in orange and green, and LPC fragment derived as NL of one FA in 366 
pink) corresponds to the color-coding of fragments assigned to proposed structures illustrated 367 
in the lower panel.  368 
3.3. Relative quantification of LPPs in air oxidized PAPC  369 
15 LPPs, including lyso PCs (LPCs), short and long chain oxidation products, were 370 
selected for relative quantification (Table 2). Before evaluating the reproducibility of PAPC 371 
air oxidation in the four different laboratories, intra- and inter-laboratory analytical variability 372 
was examined. 373 
 374 
Table 2. Elemental composition and proposed structures for the 15 LPPs in the oxPAPC 375 
mixture used for quantification. For each LPP the exact mass and m/z values for 376 
corresponding formate adduct (or m/z deprotonated ions in case of short chain LPPs with 377 
carboxylic acid terminal groups, marked with *) and protonated ions are provided.  378 
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Formula_ 
Neutral 
Proposed structures Exact mass neg m/z 
[M +HCOO
-
]
-
  
pos m/z 
[M+H
+
]
+
 
C24H50NO7P LPC(16:0) 495.3325 540.3307 496.3398 
C28H50NO7P LPC(20:4) 543.3325 588.3307 544.3398 
C29H56NO9P PC(16:0/5:0<CHO@C5>) 593.3692 638.3669 594.3670 
C29H56NO10P PC(16:0/5:0<COOH@C5>) 609.3636 608.3564* 610.3715 
C32H60NO10P PC(16:0/8:1[1OH]<CHO@C8>) 649.3949 694.3931 650.4022 
C34H62NO9P PC(16:0/10:2<CHO@C10>) 659.4157 704.4139 660.4235 
C37H66NO9P PC(16:0/13:3<CHO@C13>) 699.4470 744.4452 700.4548 
C44H78NO9P PC(16:0/20:4) +1O – 2H 795.5409 840.5391 796.5482 
C44H80NO9P PC(16:0/20:4) +1O 797.5565 842.5547 798.5638 
C44H76NO10P PC(16:0/20:4) +2O – 4H 809.5201 854.5183 810.5274 
C44H80NO10P PC(16:0/20:4) +2O 813.5514 858.5496 814.5587 
C44H78NO11P PC(16:0/20:4) +3O – 2H 827.5307 872.5289 828.5380 
C44H80NO11P PC(16:0/20:4) +2O 829.5464 874.5446 830.5536 
C44H80NO12P PC(16:0/20:4) +4O  845.5413 890.5395 846.5486 
C44H78NO13P PC(16:0/20:4) +5O – 2H 859.5205 904.5187 860.5284 
 379 
The LC-MS method used for relative LPP quantification had already been validated in 380 
different laboratories for the analysis of complex lipidomes [27,37]. To provide an estimation 381 
of the likely intra-lab accuracy of the quantification results for the LPPs, L4 evaluated intra-382 
sample as well as analytical variation (CV%) by analyzing one experimental replicate of the 383 
oxPAPC preparation for each oxidation time point on three consecutive days. Normalized 384 
peak areas were calculated for both positive and negative ion modes (Supplementary Table 385 
S2). The coefficient of variation was under 20% for all LPPs at all time points, except for 386 
LPCs at time 0 h, which showed higher inter-day variability (up to 34%), probably as the 387 
storage of the oxPAPC sample over 3 days at -80 °C does not prevent the oxidation or 388 
hydrolysis process completely. 389 
To assess inter-laboratory analytical variance, oxPAPC samples generated in L3 (0 and 390 
72h oxidation) were analyzed in three different laboratories (L1, L3 and L4). Normalized 391 
peak areas were calculated and used to perform principle component analysis (PCA; 392 
Supplementary Table S3). As expected, the analyses for the 0 and 72 h time points are well 393 
separated on the PCA plot, whereas the analytical replicates are tightly clustered. The 0 h 394 
data is also well clustered, but there is clear separation at 72h for each laboratory. The first 395 
two principle components on the PCA scores plot (Supplementary Fig. S6) explain 85 % of 396 
the variation. The first principle component demonstrates separation based on the time of 397 
PAPC air exposure, whereas second principle component (explaining 18 % of the variation) 398 
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corresponds to separation based on inter-laboratory instrument variations; samples analysed 399 
by L1 are grouped together at the bottom of the PCA scores plot, while L3 and L4 analysed 400 
samples cluster more closely together. The minor variations explained by second principle 401 
component (18%) are probably due to the type of mass analyzers used in the study (L1 - Q-402 
TOF mass spectrometer; L3 and L4 - quadrupole-Orbitrap MS).  403 
Furthermore, to compare the impact of sample preparation at different locations with 404 
the variation in analysis of a single, centrally prepared sample analyzed in different 405 
laboratories, we performed PCA of the normalized peak areas of the 72h samples generated 406 
in L3 and analysed in L1 (labeled L1a) and L4 (labeled L4a) and the samples generated 407 
independently by the four laboratories and analysed in those laboratories (L1, L2, L3, and 408 
L4) (Supplementary Tables S3 and S5, Fig. 4). It is clear that the data for the sample 409 
centrally generated in L3 but analysed at different locations cluster closely together and show 410 
minimal variation, while the samples generated in different locations showed much higher 411 
distribution. This demonstrates that the main variance was in the sample preparation, and that 412 
the analysis of the same sample at different laboratories, using three different instruments 413 
(L1:5600 TripleTOF, L3: Orbitrap Fusion™ Lumos™ Tribrid™  and L4: Q Exactive™ 414 
Plus), gave statistically very similar results. The reproducibility of analysis across the four 415 
laboratories is supported by the 0 h data in Supplementary Fig. S6, which is also tightly 416 
clustered. 417 
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 418 
Fig. 4: PCA scores plot for normalized LPPs peak area in sample generated at 72h in L3 and 419 
analysed in three different laboratories (L1a, L3 and L4a), and samples prepared 420 
independently in the four laboratories (L1, L2, L3, L4). Violet squares – L1, blue squares – 421 
L1a, blue stars – L2, pink circles – L3, yellow triangle – L4, orange triangle – L4a. 422 
Combining the results of the relative quantification of 15 LPPs from oxPAPC 423 
preparations produced and analyzed independently in four different laboratories (Fig. 5, 424 
Table 3 and Supplementary Table S4), six LPPs were among the most abundant signals in 425 
all labs and could be routinely identified and quantified, and therefore were chosen to serve 426 
as representatives of the oxPAPC mixture at the 48 and 72 h time points. 427 
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 428 
Fig. 5. Relative quantities (expressed as % of unmodified PAPC after the normalization to internal standard) of 15 representative LPPs from PAPC exposed to 429 
air oxidation for 0, 48 and 72 h. Graphs are shown for the time course at individual laboratories: L1 (A), L2 (B), L3 (C), and L4 (D) at 0 h, 48 h and 72 h. 430 
Identifications for each of the LPP masses can be found in Supplementary Table S1. 431 
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Table 3. The most abundant LPPs in air oxidized PAPC preparations for each laboratory (L1-432 
L4) quantified relative to unmodified PAPC after normalization of corresponding peak areas 433 
to internal standard.  434 
LPP, 
give as m/z values of protonated ions L1 L2 L3 L4 
594.38+ 24 %  232 % 211 % 
610.37+  39 % 99 % 195 % 
650.40+ 13 % 25 %  103 % 
814.56+ 11 %    
828.54+ 18 % 28 % 97 % 149 % 
830.55+  15 % 42 %  
846.55+ 18 % 55 % 98 % 157 % 
 435 
These correspond to three short (m/z 594.38+, 610.37+, 650.40+), and three long chain 436 
(m/z 828.55+, 830.55+, 846.55+) LPPs. Based on the results of the MS/MS identifications, the 437 
short chain LPPs can be assigned to POVPC, PGPC and HOOAPC. For the long chain LPPs 438 
each m/z value, and thus elemental composition, can correspond to several isomeric species 439 
(Table 2 and Supplementary Table S1). For instance, the LPP with elemental composition 440 
C44H78NO11P (m/z 828.55+), usually referred to in oxPAPC mixtures as epoxyisoprostane E2 441 
containing PC (PEIPC), could also be represented by the following combinations of the 442 
functional groups on a long chain LPP derived from AA: [OOH and keto], [2OH and keto], 443 
[2 epoxy and keto], and [epoxy, OH and keto]. The LPPs with elemental compositions 444 
C44H80NO11P (e.g. 3OH or OH + OOH) and C44H80NO12P (e.g. 4OH or 2OOH) are clearly 445 
represented by a mixture of isomeric structures, as some of these were at least partially 446 
separated by chromatography in this study. However, for the relative quantification reported 447 
here the total peak area for each m/z were combined to report overall abundance of all of the 448 
LPP isomers in order to be comparable with previously reported values for oxPAPC 449 
mixtures, which have commonly been analyzed by direct infusion methods where the 450 
isomeric species have not been differentiated.  451 
Although the most abundant LPPs were essentially the same between all four 452 
participating laboratories, the abundances of oxidized lipids relative to unmodified PAPC 453 
were quite different (Fig. 6). Thus, after 48 h air exposure the oxPAPC prepared in L3 454 
showed the highest oxidation levels, with POVPC being the most abundant LPP formed (245 455 
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% relative to unmodified PAPC). Among the long chain LPPs, the signals at m/z 846.55+ 456 
(128 %) and 830.54+ (96 %) were the highest after 48 h of air exposure. After 72 h exposure 457 
to the air oxidation, the highest LPPs quantities were detected in L4, with POVPC (211 %), 458 
PGPC (195 %) and long chain LPPs at m/z 846.55+ (149 %) and 830.54+ (157 %) being the 459 
most abundant.  460 
 461 
Fig. 6. Relative quantities (expressed as % of unmodified PAPC after the normalization to 462 
internal standard) of 15 LPPs in PAPC exposed to the air oxidation comparing directly the 463 
relative quantities identified in L1, L2, L3, and L4 at 48 (A) and 72 h (B).  464 
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Thus, overall relative abundances for the same LPPs produced in four laboratories 465 
differed markedly across the time course, and by up to 13.5-fold (e.g. signal at m/z 828.55+ in 466 
L1 and L4) even after 72 h of PAPC oxidation. The most variation between laboratories was 467 
seen at the 48 h time point and by 72 h the profiles in L2, 3 and 4 showed relatively similar 468 
overall abundance of oxidized products, although still with significant variation in individual 469 
species. In L1 the overall level of oxidation was still low even after 72 h. ANOVA analysis 470 
(Table S5) confirmed the statistical significance of the differences, with p-values below 0.05 471 
for all quantified LPPs except PGPC at the 72 h time point.  472 
One likely source of the difference in the oxidation rates could be small differences in 473 
the laboratory temperatures during PAPC air exposure, as average room temperatures in L1 474 
were 22-25 °C, L2 16 °C, L3 28 °C, and L4 25 °C; this could result in changes in the rate of 475 
the initiation of the free radical oxidation, which is then amplified by the radical chain 476 
reaction. The laboratory temperature at which air oxidation of oxPAPC is performed is 477 
usually not reported in publications and might be a significant confounder in reported results. 478 
However, this is clearly not the only reason, as the L1 had the lowest level of oxidation 479 
throughout, but was not the coldest laboratory. Most importantly from the point of view of 480 
experiments that are dependent on bioactivity, there is clearly significant variability in the 481 
rate of reaction and the distribution of oxidized products produced. 482 
 483 
Table 4. “Truncation score” (TS) for the oxPAPC preparations rom the four participating 484 
labs, calculated as the ratio between the summed abundances of three of the most abundant 485 
short chain LPPs (signal at m/z 594.38+, 610.37+, 650.40+) to three of the most abundant long 486 
chain LPPs (signals at m/z 828.54+, 830.55+, 846.55+).  487 
 oxPAPC TS 
 48 h 72 h 
L1 0.48 1.00 
L2 0.28 0.68 
L3 1.21 1.46 
L4 0.66 1.41 
 488 
In the literature, as a very general classification of bioactive compounds in air oxidized 489 
PAPC preparations, short chain LPPs are usually associated with pro-inflammatory effects 490 
whereas long chain LPPs are often associated with anti-inflammatory or protective functions 491 
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[17,24,25]. As is clear from the data presented above, despite the oxPAPC samples being 492 
generated in the four different laboratories using the same protocol, which required minimal 493 
sample manipulation (air exposure of the PAPC dried film), and each preparation giving rise 494 
to approximately the same set of abundant LPPs, there was a high variability in the total 495 
oxidation levels and in the extent of generation of individual LPPs. For this reason, a MS 496 
based evaluation for all in-house produced oxPAPC mixtures would be beneficial to clarify 497 
their exact composition before testing the biological effects. 498 
Furthermore, a useful marker to help to characterize oxPAPC samples could be the ratio 499 
of short to long chain oxidation products, which we suggest could be called the “truncation 500 
score” (TS). This can be calculated for each oxPAPC preparation using the simple formula 501 
TS = ∑ % of short chain LPPs/∑ % of long chain LPPs. The TS calculated using, for 502 
example, the three most abundant species from each classification (Table 3), would be 503 
indicative of the ratio between short and long chain LPPs for each preparation, which is likely 504 
to be one of the most important characteristics for bioactivity. A TS value equal to one would 505 
indicate equal contribution of short and long chain LPPs, whereas TS > 1 and TS < 1 would 506 
correspond to the prevalence of short or long chain LPPs, respectively. The results from this 507 
study using the six most abundant species are shown in Table 4. This indicates that while the 508 
overall oxidation levels from L2 and L4 at 72 h look similar in the base peak chromatograms 509 
in Fig. 1, the preparation from L2 is higher in long chain components, while that for L4 is 510 
higher in short chain. Therefore, although TS is a very rough estimation for the prevalence of 511 
short over long chain LPPs, it could be used to evaluate the oxidation state balance of 512 
oxPAPC preparations before using them in biological experiments. It is not necessary to 513 
perform full LC-MS/MS characterization to determine the TS, as direct infusion MS data, 514 
which are usually obtained to validate PAPC oxidation by air exposure for in-house 515 
preparations, could be used.  516 
One should also bear in mind that not it is not only the relative abundance of short 517 
chain over the long chain LPPs important, but their absolute concentrations are also highly 518 
significant. However, given the wide variety of chemical structures within oxPAPC mixture, 519 
and thus differences in ionization efficiency of LPPs with various functional groups, pure 520 
synthetic standards for each LPP class would be required to perform absolute quantification.  521 
4. Conclusions 522 
We have performed a multi-laboratory evaluation of air oxidized PAPC preparations 523 
from four different laboratories using LC-MS/MS analysis, focusing on the identification and 524 
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relative quantification of the LPPs formed. High intra-sample reproducibility and a very 525 
similar overall pattern of oxidation between the four laboratories was demonstrated. 526 
However, significant differences in the general extent of lipid oxidation relative to 527 
unmodified PAPC were observed. Thus, we propose that an MS based evaluation for all in 528 
house produced oxPAPC mixtures should be performed before using them to study biological 529 
effects of oxidized lipids. Furthermore, we suggest calculating the “truncation score” as a 530 
rough estimation of the balance between short vs long chain products of arachidonic acid 531 
oxidation.  532 
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• Multi-laboratory evaluation of air oxidized PAPC preparations by LC-MS/MS. 
• Identification and relative quantification of lipid peroxidation products (LPPs).  
• oxPAPC preparations should be characterized by MS prior testing biological effects of 
oxidized lipids.  
• “Truncation score” is proposed as a rough estimation of oxPAPC oxidation status. 
 
